Adaptogenics Acquires Nutritional Research Assets to Advance GLP-1 Companion Initiative

Company acquires research platform to support evidence-based products and future peptide programs for patients using GLP-1 therapies Vancouver, British Columbia – TheNewswire - October 8, 2026 — Adaptogenics Health Corp. (CSE: ADPT) (“Adaptogenics” or the “Company”) announces the acquisition of nutritional research assets developed by Berkwood Research (the “Assets”) to support a GLP-1 companion initiative focused on muscle preservation, metabolic health and functional outcomes during medically induced weight loss. The Assets include four nutritional research compositions and supporting scientific documentation comprising 36 ingredient evidence reviews, dose recommendations, product development rationale and biomarker mapping. The Company intends to use this package to select an initial GLP-1 companion concept, define measurable endpoints and establish priorities for formulation, analytical work and further testing. The four compositions provide modular research starting points across foundational metabolic and muscle support, cardiometabolic and vascular health, neurocognitive and stress support, and recovery and immune health. The underlying research includes ingredients relevant

Cancele cuando quiera · 99 CA$/mes